Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

NCT02231866 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

143

Enrollment

NIH

Sponsor class

Conditions

Healthy Adult Immune Responses to Vaccine

Interventions

BIOLOGICAL: VRC-EBOADC069-00-VP
BIOLOGICAL: VRC-EBOADC076-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)